UXS1 Antikörper (C-Term)
Kurzübersicht für UXS1 Antikörper (C-Term) (ABIN955497)
Target
Alle UXS1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 336-366, C-Term
-
Spezifität
- This antibody detects UXS1 / UGD (C-term).
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Protein A column followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 336-366 amino acids from the C-terminal region of human UXS1
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2 - 8 °C for up to six months or (in aliquots) at -20 °C for longer.
-
-
- UXS1 (UDP-Glucuronate Decarboxylase 1 (UXS1))
-
Andere Bezeichnung
- UXS1 / UGD
-
Hintergrund
- UDP-glucuronate decarboxylase (UGD, EC 4.1.1.35) catalyzes the formation of UDP-xylose from UDP-glucuronate. UDP-xylose is then used to initiate glycosaminoglycan biosynthesis on the core protein of proteoglycans.Synonyms: UDP-glucuronate decarboxylase 1, UDP-glucuronic acid decarboxylase 1, UNQ2538/PRO6079, UXS-1
-
Gen-ID
- 80146
-
NCBI Accession
- NP_079352
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-